Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

France

 

FREE BLOG Theranos may have failed, but it radically changed the lab sector

Theranos posited the idea that you could do a bunch of very low cost tests from pharmacies. Whilst it has so far failed to deliver on this, that threat has changed the sector. There are now plenty more newbies who want to do the same, such as Brainshake, whose CEO we interview here.

European listed care groups: A financial review and comparison

First half 2016 results for the major care home groups point towards solid 5-6% organic sales growth from Orpea and Korian with the latter gradually recovering from the crisis which saw the replacement of CEO Yann Coleou at the turn of 2015. Recently listed Nordic groups Attendo and Humana are benefitting from strong demand for new nursing home beds from public payors and expansion in Finland. But Swedish proposals to limit the return on public-private care services to 8% of return on equity plus net debt (before inflation) pushed shares down. Meanwhile, Middle Eastern investors have bought in to Italian operator KOS.

Publicly listed European hospital groups: Financial review and comparison

How is the European hospital sector faring? Who are the winners and losers and what does this tell us about the health of the sector? We compare first half results from the big players - Capio, Rhoen, Helios, Spire, Aevis Victoria, Ramsay Health Care and BMI (Netcare), as well as privately-held Asklepios and listed outsource specialist Pihlajalinna. There are some fascinating differences.

Ramsay shares rise on profit hike

Shares in big private hospital group Ramsay Health Care rose nearly 8% to AUD81.4. The operator which is top dog inFrance and one of the top three in the UK saw net profit after tax rise 16.8% to AUD 482m (€325 m) with group revenue ahead 18.1% to AUD 8.7bn (5.88bn) in the year to June 2016. We analyse the results.

New group forms France’s fifth largest hospital operator

Based in central France, Sisio is born out of a merger between three regional groups and the acquisition of a fourth. The result is France’s fifth largest hospital operator, a privately owned organisation with €450m revenues. We speak to Sébastien Mounier, one of its founders.

SAR’s sale on hold for the summer

Sources claim that negotiations between PAI Partners and private equity houses G-Square and Palamon to buy Spain's elderly care market leader SARquavitae are "progressing well towards a deal, but have been put on hold until September". On another note, we hear that Higinio Raventós, founder and president of SAR until 2014, passed away this morning.

Who’d buy Cerba?

Next in line in the big European lab sell-off is the French reference lab Cerba Healthcare. Cerba has plenty of potential for the right match, but with risks piling up, the price of 12-13 times EBITDA quoted in the French press looks dear. We give our analysis.

Find Us